Research Paper Volume 15, Issue 20 pp 10996—11011
BTN2A2, a new biomarker and therapeutic target for glioma
Figure 3. Survival curve for determining the prognostic significance of BTN2A2. (A–C) The significance of BTN2A2 in predicting the prognosis of patients with glioma from the TCGA cohort. (D–F) The significance of BTN2A2 in predicting the prognosis of patients with glioma using CGGA, REMBRANDT, and Phillips databases.